healthcare
Environmental solutionsnews Covering infection prevention, medical waste management & sustainable practices
VOL. XVI NO.4 3 XII NO.
www.HealthcareEnvironmentalSolutions.com
fall 2020 WINTER 2016
Current Trends for Managing Infectious Waste History
W
hile in the midst of the COVID-19 pandemic, it is an ideal time to assess the options for managing infectious waste. As we consider modern solutions, it is important to be aware of how hospitals have historically managed this waste stream. Just as recent as 25-30 years ago, most hospitals actually managed their infectious waste on-site. The technology of the time was incineration. Based on the 1990 Clean Air Act Amendments, most incinerators were ultimately shut down because they were unable to pass stack testing. Many hospitals transitioned to cleaner technologies such as autoclaves to properly treat this infectious material. However, an unintended consequence of this regulation shifted a majority of hospitals to outsource the treatment of their infectious material. Hospitals opted for this temporary solution because it required no capital investment. Many of these hospitals invested millions of dollars to upgrade their incinerators, yet they were still unable to pass air quality testing. According to Carl Solomon Sr., Director of Environmental Services at UC San Diego Health “Some states, such as California, have completely banned the incineration of medical waste due to air emission and safety concerns, requiring expensive transport and treatment of the waste off the medical center’s campus.”
by Arthur McCoy
As many hospitals are reconsidering their strategy for managing infectious waste, we will examine the justification used by many hospitals and healthcare systems that are transitioning back to an on-site model. The two business models of managing infectious waste, on-site and off-site, are dramatically different. While some off-site service vendors try to build financial and operational dependance on their respective services, the on-site model delivers the exact opposite by providing the hospital operational and financial independence from any waste service provider. Following are points that many hospitals consider while making a decision on either business model:
Disease Prevention
W
hy did so many hospitals treat on-site 2530 years ago? The underlying justification was related to basic infection control practices: treat at the point of generation. Whether it is infectious patients or infectious waste, hospitals strive to minimize these infectious outputs into their respective communities. This sentiment is very much alive today as we plan and respond to deadly emerging pathogens. Bio Safety Labs that have a rating of 4 (BSL4) are used for studying and containing such exotic pathogens as Ebola Virus, smallpox, and Lassa Virus. Such labs are required to autoclave their infectious waste prior to leaving the facility.1
Emergency Readiness/PPE
T
he reality for hospitals is that we could continue to see an uptick in these emerging diseases. As a result, many hospitals are now looking to include on-site treatment infrastructure as a proactive health and safety measure to prevent the further spread of disease. In order to protect our healthcare heroes, PPE supplies must be fortified. Some infectious waste treatment technologies are going through the approval procedure with the FDA to reprocess certain types of PPE. The reprocessing of PPE would expand domestic inventories.
Continued on page 3
Cleveland, OH Permit #1737
PAID
U.S. Postage
PRSRT STD